Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2024-511153-21-00Phase 4Authorised
Phase 4, randomised trial of Isolyte in Brain disorder (2 arms), sponsored by Fakultní nemocnice Brno. Primary endpoint: Incidence of adverse events and reactions (Adverse Events of Special Interest). Planned start Jun 2024; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2024-511153-21-00.